Search research articles
Contact Us
Filters
Showing results (81-90 of 297) with videos related to
Page
of 30
Sort By:
Journal of Neuro-Oncology
|
January 15, 2014
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
Véronique Quillien, Audrey Lavenu, Marc Sanson, et al.
World Neurosurgery
|
March 13, 2024
Implications of DNA Methylation Classification in Diagnosing Ependymoma
Eiji Abe, Mario Suzuki, Koichi Ichimura, et al.
Neuro-Oncology Advances
|
July 13, 2022
Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
Kazuhiko Kurozumi, Kentaro Fujii, Kana Washio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 9, 2004
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
Aya Seida, Jun Wada, Yoshitaka Morita, et al.
Brain Tumor Pathology
|
August 24, 2017
Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma
Taishi Nakamura, Kohei Fukuoka, Junji Ikeda, et al.
Brain Tumor Pathology
|
July 14, 2012
Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
Makoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Oncology Letters
|
June 29, 2012
Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies
Tsuyoshi Ueno, Junichi Soh, Takao Hiraki, et al.
International Journal of Oncology
|
July 25, 2012
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, et al.
Journal of Surgical Case Reports
|
May 24, 2021
Radical surgery for anal canal neuroendocrine carcinoma with pagetoid spread: a case report
Sotaro Fukuhara, Masanori Yoshimitsu, Takuya Yano, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
November 3, 2023
Embryonal tumor with multilayered rosettes arising from the internal auditory canal of an adult: Illustrative case with molecular investigations
Adam Sheriff, Hirokazu Takami, Shunsaku Takayanagi, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 297) with videos related to
Sort By:
Page
of 30
Journal of Neuro-Oncology
|
January 15, 2014
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
Véronique Quillien, Audrey Lavenu, Marc Sanson, et al.
World Neurosurgery
|
March 13, 2024
Implications of DNA Methylation Classification in Diagnosing Ependymoma
Eiji Abe, Mario Suzuki, Koichi Ichimura, et al.
Neuro-Oncology Advances
|
July 13, 2022
Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
Kazuhiko Kurozumi, Kentaro Fujii, Kana Washio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 9, 2004
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
Aya Seida, Jun Wada, Yoshitaka Morita, et al.
Brain Tumor Pathology
|
August 24, 2017
Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma
Taishi Nakamura, Kohei Fukuoka, Junji Ikeda, et al.
Brain Tumor Pathology
|
July 14, 2012
Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status
Makoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Oncology Letters
|
June 29, 2012
Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies
Tsuyoshi Ueno, Junichi Soh, Takao Hiraki, et al.
International Journal of Oncology
|
July 25, 2012
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, et al.
Journal of Surgical Case Reports
|
May 24, 2021
Radical surgery for anal canal neuroendocrine carcinoma with pagetoid spread: a case report
Sotaro Fukuhara, Masanori Yoshimitsu, Takuya Yano, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
November 3, 2023
Embryonal tumor with multilayered rosettes arising from the internal auditory canal of an adult: Illustrative case with molecular investigations
Adam Sheriff, Hirokazu Takami, Shunsaku Takayanagi, et al.
Page
of 30